Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections선행 리툭시맙 유지 요법을 받은 여포성 림프종 환자에서 1년 지속되는 COVID-19 폐렴의 해결 및 면역 혈소판 감소증의 발병: 장기간 감염 사례에 대한 후속 보고서 및 문헌 검토Review Published on 2021-10-012022-09-11 Journal: Clinical lymphoma, myeloma & leukemia [Category] MERS, SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibodies antibody approach Case report cellular immunity Chemotherapy convalescent plasma Convalescent plasma therapy coronavirus Course COVID-19 COVID-19 infection COVID-19 infections COVID-19 pneumonia development died disease course follicular Follicular lymphoma Follow-up Humoral immunity Immune thrombocytopenia Immunocompromised Itp. literature literature review lymphoma maintenance material Patient patients Pneumonia Prolonged prolonged disease receive report reported Resolution review risk rituximab subsequent T-cell Response the disease thrombocytopenia time-consuming [DOI] 10.1016/j.clml.2021.07.004 PMC 바로가기 [Article Type] Review
Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTechMedicine Published on 2021-09-302022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] administration adverse event age Autoimmune disease baseline bleeding BNT162b2 BNT162b2 vaccine ChAdOx1 condition COVID-19 cranial death death case deaths feature General population hemorrhage hemorrhages hypertension Immune thrombocytopenia interfere Japan Mild Ministry of Health Patient Pfizer-BioNTech Post-vaccine Potential raised renal reported required rheumatoid arthritis risk severe cases statistically the vaccine thrombocytopenia thrombosis Trigger vaccination Vaccine Welfare women [DOI] 10.3389/fmed.2021.751598 PMC 바로가기 [Article Type] Medicine
Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature ReviewNeurology Published on 2021-09-242022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] accompanied antibody Anticoagulants Autoimmune diseases cerebral cerebral venous sinus thrombosis correlation COVID-19 D-dimer D-dimer levels diagnosed Diagnosis disease dural sinus thrombosis elevated Embolism Emergency fatal complication headache high mortality rate High-dose immune Immune-mediated Immunoglobulin initiated Intravenous immunoglobulin Laboratory literature male nausea neurologic Neurological deficit Patient physician Platelet positive presenting prothrombotic protocol pulmonary Pulmonary embolism report review Sinus steroid Steroids thrombocytopenia thrombotic treated Treatment vaccination vaccine-induced immune thrombotic thrombocytopenia vomiting worsening [DOI] 10.3389/fneur.2021.738329 PMC 바로가기 [Article Type] Neurology
Platelet-Based Biomarkers for Diagnosis and Prognosis in COVID-19 PatientsCommunication Published on 2021-09-242022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] acute respiratory syndrome analyzed Biomarker C-reactive protein can be used caused clinical manifestation Coagulation Cohort Combination coronavirus Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity creatinine death develop Hospitalization hypercoagulable identify infections Inflammation Inflammatory Inflammatory biomarker Inflammatory marker intensive care investigated laboratory data manuscript moderate multiple organ failure Nasopharyngeal swab neutrophil count Neutrophil-to-lymphocyte ratio no symptom outcome outcomes Patient patients with COVID-19 Platelet predict Predictive Prognosis risk RNA SARS-CoV-2 Sepsis severe COVID-19 severity the disease the patient thrombocytopenia transferred urea [DOI] 10.3390/life11101005 PMC 바로가기 [Article Type] Communication
Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in EmergencyBrief Report Published on 2021-09-222022-10-30 Journal: Medicina [Category] COVID-19, SARS, [키워드] anti-SARS-CoV-2 vaccine Asia Bacteria country COVID-19 develop diffusion Emergency Hospitalization Immune thrombocytopenia involved Lung injury mechanism morbidity pandemic Pathogenesis Protective prothrombotic question raise reduce reported SARS-CoV-2 severe pneumonia therapeutic strategy thrombocytopenia thrombosis vaccination Vaccine Venous Thromboembolism viral infection [DOI] 10.3390/medicina57100997 PMC 바로가기 [Article Type] Brief Report
Impact of interventions on the incidence of natural focal diseases during the outbreak of COVID-19 in Jiangsu Province, China중국 장부 지방에서 Covid-19가 발생하는 동안 자연 국소 질환의 발생률에 대한 중재의 영향Research Published on 2021-09-192022-09-01 Journal: Parasites & Vectors [Category] 말라리아, 진단, [키워드] adopted age ARIMA average brucellosis CDC center China collected confirmed case Control coronavirus disease Coronavirus disease 2019 COVID-19 Dengue described diagnosed disease disease control Diseases distribution Encephalitis Epidemics evaluate Fever goodness of fit help Hemorrhagic hemorrhagic fever illness onset Impact incidence Infectious diseases Intervention Japanese encephalitis Jiangsu lockdown malaria male males measure Measures moving average natural Natural focal diseases nonparametric test Nonparametric tests other infectious diseases outbreak predicted prevention Prevention and control R 2 rabies renal reported Result rural areas Sex Spread statistically significant Suspension syndrome thrombocytopenia Travel was used were used [DOI] 10.1186/s13071-021-04986-x PMC 바로가기 [Article Type] Research
Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young WomanInternal Medicine Published on 2021-09-132022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Adverse adverse effect ameliorated approved association bleeding coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine Dexamethasone diagnosed effective exacerbated Exacerbation fatigue headache High-dose high-dose dexamethasone Immune thrombocytopenia immune-mediated thrombocytopenia individual joint mechanism Pain pandemic Pfizer pfizer biontech covid-19 vaccine Platelet receive receiving reported Reporting SARS-CoV2 second dose severe adverse event System therapy thrombocytopenia vaccination woman young woman [DOI] 10.7759/cureus.17942 PMC 바로가기 [Article Type] Internal Medicine
Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya서부 케냐의 농촌 지역에서 무증상 말라리아와 주혈흡충증 동시 감염의 역학적 및 임상적 의미Research Published on 2021-09-092024-08-08 Journal: BMC Infectious Diseases [Category] 말라리아, [키워드] Asymptomatic malaria creatinine eosinophilia hematological Kenya Plasmodium falciparum Schistosomiasis thrombocytopenia [DOI] 10.1186/s12879-021-06626-2 PMC 바로가기 [Article Type] Research
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in ThailandCase Report Published on 2021-09-082022-10-29 Journal: Thrombosis Journal [Category] COVID-19, [키워드] administration Admission aggregation antibody Anticoagulant Asian AstraZeneca Case report ChAdOx1 nCoV-19 vaccine Clinical outcome COVID-19 vaccine demonstrated Dexamethasone discharged Early detection elevated fatal complication female Follow-up headache High-dose hospital Hospitalization immune IMPROVE induce Intravenous immunoglobulin occur optical Patient Platelet positive Prevent prophylactic dose reported thrombocytopenia Thromboprophylaxis thrombosis thrombotic treat Treatment Vaccine vaccine-induced immune thrombotic thrombocytopenia venous [DOI] 10.1186/s12959-021-00317-3 PMC 바로가기 [Article Type] Case Report
Intracerebral Hemorrhage and Thrombocytopenia After AstraZeneca COVID-19 Vaccine: Clinical and Diagnostic Challenges of Vaccine-Induced Thrombotic ThrombocytopeniaInfectious Disease Published on 2021-09-012022-10-31 Journal: Cureus [Category] COVID-19, [키워드] adverse effect antibody AstraZeneca AstraZeneca vaccine ChAdOx1 nCoV-19 challenge clinical clinical history coronavirus disease COVID-19 COVID-19 vaccine described Diagnosis disorder ELISA enzyme-linked immunosorbent first dose functional heparin HIPAA immune individual Intracerebral hemorrhage Oxford-AstraZeneca Patient PF4 platelet activation positive prothrombotic receiving SARS-CoV-2 tested thrombocytopenia thrombosis thrombotic Vaccines [DOI] 10.7759/cureus.17637 PMC 바로가기 [Article Type] Infectious Disease